Skip to the page

Data / Drug companies / American Pacific Corporation

American Pacific Corporation: 32 products in the FDA NDC directory, labeler code 50683

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

American Pacific Corporation (labeler code 50683) lists 32 products in the FDA National Drug Code Directory. By type: 32 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 5, 2025.

The request: Watch American Pacific Corporation (FDA labeler code 50683): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
50683
Products in commercial distribution
32
Packages
32
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule II 4
Started marketing in the last 12 months
0
Earliest marketing start
January 1, 1972
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients3196.9%
Bulk ingredients for compounding13.1%

Products by type

TypeProductsShare
Bulk ingredients32100%

Dosage forms

Dosage formProductsShare
Powder32100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ldf 3a50683-0660PowderBulk ingredientsMay 5, 2025
Crystalline rta 40850683-0525PowderBulk ingredientsFebruary 28, 2023
Etrasimod l-arginine50683-0677PowderBulk ingredientsSeptember 30, 2022
Apd334 l-arginine50683-0534PowderBulk ingredientsSeptember 30, 2022
Acalabrutinib maleate50683-0611PowderBulk ingredientsAugust 3, 2022
Finerenone50683-0540PowderBulk ingredientsApril 8, 2022
Molnupiravir50683-0596PowderBulk ingredientsNovember 17, 2021
Sotorasib50683-0573PowderBulk ingredientsNovember 17, 2021
Loxo-29250683-0547PowderBulk ingredientsNovember 9, 2021
Ruxolitinib phosphate50683-0597PowderBulk ingredientsNovember 1, 2021
Vibegron50683-0536PowderBulk ingredients for compoundingOctober 14, 2021
Labetalol hydrochloride50683-0590PowderBulk ingredientsApril 13, 2021
Oseltamivir phosphate50683-0557PowderBulk ingredientsApril 13, 2021
Remifentanil hydrochloride50683-0550PowderBulk ingredientsOctober 22, 2020
Thiotepa50683-0465PowderBulk ingredientsJanuary 13, 2020
Levorphanol tartrate50683-0514PowderBulk ingredientsDecember 6, 2019
Ruxolitinib phosphate50683-0340PowderBulk ingredientsAugust 16, 2018
Dex-methylphenidate hydrochloride50683-0428PowderBulk ingredientsSeptember 4, 2017
Cyclophosphamide monohydrate50683-0468PowderBulk ingredientsMay 1, 2017
Melphalan, sieved50683-0520PowderBulk ingredientsMarch 1, 2017
Brigatinib50683-0420PowderBulk ingredientsDecember 9, 2016
Sofosbuvir50683-0412PowderBulk ingredientsMay 1, 2013
Ruxolitinib phosphate50683-0440PowderBulk ingredientsOctober 11, 2011
Busulfan50683-0363PowderBulk ingredientsOctober 1, 2010
Thioguanine50683-0356PowderBulk ingredientsMarch 1, 2010

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.